These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 633484)

  • 1. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB; Gunnarsson PO; Nilsson T; Forshell GP
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
    Sandberg AA
    Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075
    [No Abstract]   [Full Text] [Related]  

  • 4. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I; Liskowski L; Nilsson T
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
    Kadohama N; Kirdani RY; Madajewicz S; Murphy GP; Sandberg AA
    N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893
    [No Abstract]   [Full Text] [Related]  

  • 7. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of estramustine phosphate.
    Gunnarsson PO; Forshell GP
    Urology; 1984 Jun; 23(6 Suppl):22-7. PubMed ID: 6375076
    [No Abstract]   [Full Text] [Related]  

  • 9. Estramustine phosphate sodium.
    Hauser AR; Merryman R
    Drug Intell Clin Pharm; 1984 May; 18(5):368-74. PubMed ID: 6373212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hydrolysis of estramustine phosphate; in vitro studies.
    Gunnarsson O; Andersson SB; Johansson SA
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):395-402. PubMed ID: 6673977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estramustine-binding protein in rat and human prostate.
    Forsgren B
    Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific binding of estramustine to prostatic proteins.
    Forsgren B; Björk P
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract]   [Full Text] [Related]  

  • 16. Design of cytotoxic steroids for prostate cancer.
    Petrow V; Padilla GM
    Prostate; 1986; 9(2):169-82. PubMed ID: 3748896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD; Rozencweig M; Slavik M; Muggia FM
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of Emcyt.
    Høisaeter PA
    Urology; 1984 Jun; 23(6 Suppl):46-8. PubMed ID: 6375079
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
    Kirdani RY; Karr JP; Murphy GP; Sandberg AA
    N Y State J Med; 1980 Aug; 80(9):1390-3. PubMed ID: 6938806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.